First human test for new drug compares effects across ethnic groups
NCT ID NCT07361354
Summary
This is an early-stage study to understand how a new drug called AGA2118 moves through the body in healthy people. It will enroll 30 healthy Japanese, Chinese, and Caucasian volunteers to receive a single dose. The main goal is to measure the drug's levels in the blood over time and check for safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Los Angeles EPCU
RECRUITINGGlendale, California, 91206, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.